MONTAI.COM: Keyword Density Checker

Total words: 2926 | 2-word phrases: 789 | 3-word phrases: 846 | 4-word phrases: 858

PAGE INFO

Title	Try to keep the title under 60 characters (51 characters) Montai Therapeutics \| A Flagship Pioneering Company
Description	Try to keep the meta description between 50 - 160 characters (121 characters) Breakthrough small molecule medicines for chronic disease with unprecedented pathway precision and predictable discovery.
Keywords	Meta keywords are not recommended anymore (0 characters)
H1	No H1 tag on the page (0 characters)

#	Keyword	Frequency	Density
1	predictable discovery of	3	0.35%
2	small molecule drugs	3	0.35%
3	small molecule drug	3	0.35%
4	flagship pioneering company	2	0.24%
5	the conecta™ platform	2	0.24%
6	2023 read on	2	0.24%
7	on business wire	2	0.24%
8	read on business	2	0.24%
9	2024 read on	2	0.24%
10	transformative small molecule	2	0.24%
11	of transformative small	2	0.24%
12	discovery of transformative	2	0.24%
13	are safe for	1	0.12%
14	potential to replace	1	0.12%
15	the growing and	1	0.12%
16	platform has generated	1	0.12%
17	has generated multiple	1	0.12%
18	promising candidates that	1	0.12%
19	candidates that have	1	0.12%
20	that have the	1	0.12%
21	have the potential	1	0.12%
22	to replace biologics	1	0.12%
23	our conecta platform	1	0.12%
24	replace biologics or	1	0.12%
25	reduce the growing	1	0.12%
26	effectively engage targets	1	0.12%
27	engage targets that	1	0.12%
28	targets that have	1	0.12%
29	that have historically	1	0.12%
30	have historically been	1	0.12%

#	Keyword	Frequency	Density
1	discovery of transformative small	2	0.23%
2	of transformative small molecule	2	0.23%
3	read on business wire	2	0.23%
4	transformative small molecule drugs	2	0.23%
5	predictable discovery of transformative	2	0.23%
6	inflammationrelated pathways also offer	1	0.12%
7	pathways also offer important	1	0.12%
8	biological network links to	1	0.12%
9	network links to other	1	0.12%
10	links to other chronic	1	0.12%
11	to other chronic diseases	1	0.12%
12	other chronic diseases such	1	0.12%
13	skip to content primary	1	0.12%
14	earlier intervention inflammationrelated pathways	1	0.12%
15	chronic diseases such metabolism	1	0.12%
16	neurology and oncology our	1	0.12%
17	and oncology our conecta	1	0.12%
18	oncology our conecta platform	1	0.12%
19	our conecta platform has	1	0.12%
20	conecta platform has generated	1	0.12%
21	platform has generated multiple	1	0.12%
22	promising candidates that have	1	0.12%
23	candidates that have the	1	0.12%
24	intervention inflammationrelated pathways also	1	0.12%
25	are safe for longterm	1	0.12%
26	for longterm use and	1	0.12%
27	diseases given the enormous	1	0.12%
28	complex targets our initial	1	0.12%
29	targets our initial focus	1	0.12%
30	our initial focus is	1	0.12%
31	initial focus is on	1	0.12%
32	focus is on inflammatory	1	0.12%
33	is on inflammatory and	1	0.12%
34	autoimmune diseases given the	1	0.12%
35	given the enormous unmet	1	0.12%
36	safe for longterm use	1	0.12%
37	the enormous unmet patient	1	0.12%
38	enormous unmet patient needs	1	0.12%
39	unmet patient needs for	1	0.12%
40	efficacious accessible therapies that	1	0.12%

#	URL	Whois	Check
1	https://www.flagshippioneering.com?utm_source=montai	Whois	flagshippioneering.com
2	https://www.linkedin.com/company/montai-health/	Whois	linkedin.com
3	https://twitter.com/MontaiHealth	Whois	twitter.com
4	https://www.flagshippioneering.com?utm_source=montai	Whois	flagshippioneering.com